Anavex life sciences announces grant of u.s. patent covering blarcamesine (anavex®2-73) for treatment of neurodevelopmental disorders

Grant of its newest u.s. patent expands anavex's intellectual property portfolio in neurologic indications grant of its newest u.s. patent expands anavex's intellectual property portfolio in neurologic indications

AVXL Ratings Summary

AVXL Quant Ranking